CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Unaudited) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Income	Total
Balance, beginning at Dec. 31, 2018	$ 47,895	$ 90,770,682	$ (76,435,235)	$ 207,754	$ 14,591,096
Balance, beginning (in shares) at Dec. 31, 2018	478,950,996
Sale of common stock for cash	$ 3,876	2,924,395			2,928,271
Sale of common stock for cash (in shares)	38,763,750
Common stock issued for services	$ 41	41,071			41,112
Common stock issued for services (in shares)	410,708
Warrant exercise
Stock-based compensation		1,066,270			1,066,270
Stock-based compensation (in shares)
Net loss			(6,796,766)		(6,796,766)
Foreign currency translation				(12,345)	(12,345)
Balance, ending at Sep. 30, 2019	$ 51,812	94,802,418	(83,232,001)	195,409	11,817,638
Balance, ending (in shares) at Sep. 30, 2019	518,125,454
Balance, beginning at Jun. 30, 2019	$ 51,812	94,427,749	(80,873,765)	221,456	13,827,252
Balance, beginning (in shares) at Jun. 30, 2019	518,125,454
Collection of subscription receivable		100,000			100,000
Stock-based compensation		274,669			274,669
Net loss			(2,358,236)		(2,358,236)
Foreign currency translation				(26,047)	(26,047)
Balance, ending at Sep. 30, 2019	$ 51,812	94,802,418	(83,232,001)	195,409	11,817,638
Balance, ending (in shares) at Sep. 30, 2019	518,125,454
Balance, beginning at Dec. 31, 2019	$ 51,812	94,982,167	(86,935,593)	177,385	$ 8,275,771
Balance, beginning (in shares) at Dec. 31, 2019	518,125,454				518,125,454
Sale of common stock for cash	$ 344	199,656			$ 200,000
Sale of common stock for cash (in shares)	3,441,558
Warrant exercise	$ 2,048	1,246,935			1,248,983
Warrant exercise (in shares)	20,480,992
Warrant and stock option cashless exercises	$ 133	(133)
Warrant and stock option cashless exercises, shares	1,332,228
Modification of warrants issued with debt		95,223			95,223
Warrant exercise inducement		366,795			366,795
Stock-based compensation	$ 450	741,218			741,668
Stock-based compensation (in shares)	4,500,000
Issuance of common stock to settle accounts payable	$ 11	8,259			8,270
Issuance of common stock to settle accounts payable, shares	106,192
Net loss			(9,217,108)		(9,217,108)
Foreign currency translation				(6,972)	(6,972)
Balance, ending at Sep. 30, 2020	$ 54,798	97,640,120	(96,152,701)	170,413	$ 1,712,630
Balance, ending (in shares) at Sep. 30, 2020	547,986,424				547,986,424
Balance, beginning at Jun. 30, 2020	$ 54,665	97,528,578	(94,234,462)	141,356	$ 3,490,137
Balance, beginning (in shares) at Jun. 30, 2020	546,654,196
Warrant and stock option cashless exercises	$ 133	(133)
Warrant and stock option cashless exercises, shares	1,332,228
Stock-based compensation		111,675			111,675
Stock-based compensation (in shares)
Net loss			(1,918,239)		(1,918,239)
Foreign currency translation				29,057	29,057
Balance, ending at Sep. 30, 2020	$ 54,798	$ 97,640,120	$ (96,152,701)	$ 170,413	$ 1,712,630
Balance, ending (in shares) at Sep. 30, 2020	547,986,424				547,986,424